ALZN
Price
$1.13
Change
-$0.12 (-9.60%)
Updated
Dec 20, 04:59 PM (EDT)
BPMUF
Price
$52.83
Change
+$1.57 (+3.06%)
Updated
Oct 11 closing price
Ad is loading...

ALZN vs BPMUF

Header iconALZN vs BPMUF Comparison
Open Charts ALZN vs BPMUFBanner chart's image
Alzamend Neuro
Price$1.13
Change-$0.12 (-9.60%)
Volume$2.06K
CapitalizationN/A
Basilea Pharmaceutica AG
Price$52.83
Change+$1.57 (+3.06%)
Volume$135
CapitalizationN/A
ALZN vs BPMUF Comparison Chart
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. BPMUF commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Hold and BPMUF is a Buy.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (ALZN: $1.14 vs. BPMUF: $52.83)
Brand notoriety: ALZN and BPMUF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 375% vs. BPMUF: 100%
Market capitalization -- ALZN: $6.19M vs. BPMUF: $561.52M
ALZN [@Biotechnology] is valued at $6.19M. BPMUF’s [@Biotechnology] market capitalization is $561.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileBPMUF’s FA Score has 1 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • BPMUF’s FA Score: 1 green, 4 red.
According to our system of comparison, BPMUF is a better buy in the long-term than ALZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 5 TA indicator(s) are bullish while BPMUF’s TA Score has 1 bullish TA indicator(s).

  • ALZN’s TA Score: 5 bullish, 3 bearish.
  • BPMUF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than BPMUF.

Price Growth

ALZN (@Biotechnology) experienced а -4.20% price change this week, while BPMUF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ALZN is expected to report earnings on Jan 03, 2024.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMUF($562M) has a higher market cap than ALZN($6.19M). BPMUF YTD gains are higher at: 28.854 vs. ALZN (-87.191). BPMUF has higher annual earnings (EBITDA): -4.5M vs. ALZN (-12.35M). BPMUF has more cash in the bank: 63M vs. ALZN (283K). ALZN has less debt than BPMUF: ALZN (345K) vs BPMUF (112M). BPMUF has higher revenues than ALZN: BPMUF (149M) vs ALZN (0).
ALZNBPMUFALZN / BPMUF
Capitalization6.19M562M1%
EBITDA-12.35M-4.5M274%
Gain YTD-87.19128.854-302%
P/E RatioN/A51.42-
Revenue0149M-
Total Cash283K63M0%
Total Debt345K112M0%
FUNDAMENTALS RATINGS
BPMUF: Fundamental Ratings
BPMUF
OUTLOOK RATING
1..100
44
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
32
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNBPMUF
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
18%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
13%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 5 days ago
17%
View a ticker or compare two or three
Ad is loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNSB18.710.41
+2.24%
MainStreet Bancshares
BON1.470.02
+1.19%
Bon Natural Life Limited
MEDP337.572.42
+0.72%
Medpace Holdings
CNXC40.480.10
+0.25%
Concentrix Corp
FLGT18.34-0.41
-2.19%
Fulgent Genetics

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-8.80%
SRPT - ALZN
49%
Loosely correlated
-0.42%
NCNA - ALZN
45%
Loosely correlated
-0.83%
VRAX - ALZN
41%
Loosely correlated
-7.41%
SNSE - ALZN
41%
Loosely correlated
+4.63%
BPMUF - ALZN
36%
Loosely correlated
N/A
More

BPMUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMUF has been loosely correlated with AAVXF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMUF jumps, then AAVXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMUF
1D Price
Change %
BPMUF100%
N/A
AAVXF - BPMUF
47%
Loosely correlated
N/A
ABCZF - BPMUF
38%
Loosely correlated
N/A
ALZN - BPMUF
36%
Loosely correlated
-8.80%
GTBP - BPMUF
29%
Poorly correlated
-8.03%
NCNA - BPMUF
28%
Poorly correlated
-0.83%
More